Thomas Fuller | SOPA Images | Lightrocket | Getty Images
Denmark's Novo Nordisk said connected Thursday it has made an unsolicited bid for U.S. cause shaper Metsera, aft Pfizer past week made an connection for the company.
Novo said it had offered $56.50 per stock successful currency for Metsera, corresponding to an endeavor worth of $6 billion, portion Pfizer past week said it would wage $47.50 per stock successful cash, representing $4.9 cardinal successful endeavor value.
Both Novo and Metsera besides offered contingent worth rights (CVRs) that could adhd respective cardinal dollars to the acquisition price, based connected the accomplishment of objective and regulatory milestones.
English (US) ·